Table 2

 Major groups of diseases stratified for sex and age at death, comparison between patients with MG and matched controls

Age at deathMale patients (n = 100)Male controls (n = 500)pFemale patients (n = 149)Female controls (n = 745)p
The fraction, as well as the percentage (in brackets), shows the occurrence of the disease compared with all deceased individuals of the same sex who died in the same time period. * Pearson x2 tests were used. Statistical significance.
Respiratory tract disease
    0–29 years0/20/101/4 (25.0)0/140.05
    30–49 years3/6 (50.0)1/25 (4.0)0.003*4/22 (18.2)4/50 (8.0)0.21
    50–69 years12/36 (33.3)14/127 (11.0)0.001*14/48 (29.2)24/179 (13.4)0.009*
    ⩾70 years20/56 (35.7)89/338 (26.3)0.1516/75 (21.3)128/502 (25.5)0.44
    Total35/100 (35.0)104/500 (20.8)0.002*35/149 (23.5)156/745 (20.9)0.49
Cardiac disease
    0–29 years0/20/100/41/14 (7.1)0.58
    30–49 years0/68/25 (32.0)0.112/22 (9.1)6/50 (12.0)0.72
    50–69 years7/36 (19.4)66/127 (52.0)0.001*7/48 (14.6)53/179 (29.6)0.036*
    ⩾70 years22/56 (39.3)179/338 (53.0)0.0634/75 (45.3)227/502 (45.2)0.99
    Total29/100 (29.0)253/500 (50.6)<0.001*43/149 (28.9)287/745 (38.5)0.026*
Malignant disease
    0–29 years0/20/100/43/14 (21.4)0.31
    30–49 years0/63/25 (12.0)0.371/22 (4.5)23/50 (46.0)0.001*
    50–69 years4/36 (11.1)36/127 (28.3)0.034*5/48 (10.4)93/179 (52.0)<0.001*
    ⩾70 years7/56 (12.5)72/338 (21.3)0.135/75 (6.7)109/502 (21.7)0.002*
    Total11/100 (11.0)111/500 (22.2)0.011*11/149 (7.4)228/745 (30.6)<0.001*
Cerebrovascular disease
    0–29 years0/20/100/41/14 (7.1)0.58
    30–49 years1/6 (16.7)2/25 (8.0)0.520/225/50 (10.0)0.12
    50–69 years1/36 (2.8)15/127 (11.8)0.113/48 (6.3)17/179 (9.5)0.48
    ⩾70 years10/56 (17.9)66/338 (19.5)0.7710/75 (13.3)121/502 (24.1)0.038*
    Total12/100(12.0)83/500 (16.6)0.2513/149 (8.7)144/745 (19.3)0.002*